Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

DIGITAL HEALTH IN PRACTICE AND OVERCOMING DIGITAL FATIGUE

During this year’s Reuters event, Pharma 2022, WebMD CMO, Dr John Whyte discussed the ways in which digital health is growing, and the importance of educating clinicians in the right...

Medscape Education

- PMLiVE

Developing a portfolio strategy

Approaches to portfolio strategy have become more holistic across the healthcare industry, but what are the benefits for business?

- PMLiVE

AstraZeneca to acquire Neogene Therapeutics in $320m deal

The agreement will build the company’s pipeline of cell-based cancer treatments

- PMLiVE

UK Government announces £113m to tackle ‘biggest’ public health challenges

A taskforce model, similar to the one that delivered COVID-19 vaccines, will be used

- PMLiVE

National trial to rapidly find treatments for severe flu this winter launched in UK

REMAP-CAP will test multiple treatments at the same time in thousands of people

- PMLiVE

Alzheimer’s Research UK welcomes government’s recommitment to dementia mission

One million people are predicted to be living with dementia by 2025, increasing to 1.6 million by 2040

- PMLiVE

Almirall set to participate in Innovative Medicines Initiative’s FACILITATE project

The project aims to return clinical trial data to participants, readying it for reuse in future research

Board Members

OPEN Health Appoints David P. King as Non-Executive Chairman and Paul Carter as Independent Board Member

OPEN Health has announced additions to its board of directors, appointing David P. King as non-executive Chairman and Paul Carter as an independent board member.

OPEN Health

Mike Bushell presenting PMEA award to two Bedrock employees

Bedrock Healthcare Communications is proud to accept the PMEA for Agility in Pharma Market Excellence

Recognition for a bold and imaginative approach to an actionable clinical consensus for MS patients.

Bedrock Healthcare Communications

- PMLiVE

The role of digital health technology tools in supporting medical adherence

How DHT-based digital interventions can help to support patients and improve adherence

- PMLiVE

AstraZeneca and C4X Discovery sign exclusive $403m licensing deal

The collaboration aims to develop an oral therapy for inflammatory and respiratory diseases

Bayer symbol

Bayer’s Nubeqa receives MHRA approval to treat metastatic prostate cancer

The treatment will be made available immediately through an early access deal with NHS England

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links